Tilray's Q3 earnings show promising signs of improving fundamentals with expanding margins and effective cost management, combined with a clean balance sheet. Management's strategy shift to prioritizing profitable growth offers a viable path to long-term profitability. Despite improving fundamentals, Tilray appears to be undervalued, in my opinion.
Tilray Brands, Inc. (NASDAQ:TLRY ) Q3 2025 Earnings Conference Call April 8, 2025 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs & Communications Officer Irwin Simon - Chairman & Chief Executive Officer Ty Gilmore - President, Tilray Beverages North America Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer & Head, International Jared Simon - President, Manitoba Harvest & Tilray Wellness at Manitoba Harvest Hemp Foods. Conference Call Participants Aaron Grey - Alliance Global Partners Victor Ma - TD Securities Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Matt Bottomley - Canaccord Genuity Michael Lavery - Piper Sandler Operator Thank you for joining today's conference call to discuss Tilray Brands Financial Results for the fiscal 2025 third quarter ended February 28, 2025.
Tilray Inc (NASDAQ:TLRY) shares plunged more than 16% after the cannabis and consumer packaged goods-producer's fiscal third quarter financial report disappointed investors. Revenue fell year-over-year to $185.8 million from $188.3 million, well below expectations of $209.8 million.
The headline numbers for Tilray Brands (TLRY) give insight into how the company performed in the quarter ended February 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to break-even earnings per share a year ago.
Tilray Brands (TLRY -4.48%) went public in the U.S. in 2018 when cannabis was among Wall Street's hottest topics. However, despite the cannabis market surpassing $38 billion last year in the U.S. alone, Tilray has been a colossal disappointment.
Many valuation metrics suggest that Tilray Brands (TLRY -0.70%) is a screaming buy right now. Just look at the cannabis stock's price-to-sales ratio.
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.66, moving -0.78% from the previous trading session.
Anytime a company within the chronically struggling marijuana industry sees a leap in stock price, it's notable. That happened on Thursday with top Canadian cannabis company Tilray Brands (TLRY 8.50%), following news of a development in the legal sphere.
Tilray Brands stock price has imploded and currently trades at a record low as concerns about its cannabis business remain. TLRY was trading at $0.65 on Thursday, bringing its market cap to $589 million.
In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $0.65, indicating a +0.23% shift from the previous trading day.
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $0.65, representing a +0.98% change from its previous close.